Authors: KATZ RI LEVY A SLEPIAN B SOBEL B LAGASSE RS

Citation: Ri. Katz et al., HEMODYNAMIC STABILITY AND KETAMINE-ALFENTANIL ANESTHETIC INDUCTION, British Journal of Anaesthesia, 81(5), 1998, pp. 702-706

Authors: CALLESESCANDON J BALLOR D HARVEYBERINO J ADES P TRACY R SOBEL B

Citation: J. Callesescandon et al., AMELIORATION OF THE INHIBITION OF FIBRINOLYSIS IN ELDERLY, OBESE SUBJECTS BY MODERATE ENERGY-INTAKE RESTRICTION, The American journal of clinical nutrition, 64(1), 1996, pp. 7-11

Authors: SCHARFSTEIN JS ABENDSCHEIN DR EISENBERG PR GEORGE D CANNON CP BECKER RC SOBEL B CUPPLES LA BRAUNWALD E LOSCALZO J

Citation: Js. Scharfstein et al., USEFULNESS OF FIBRINOGENOLYTIC AND PROCOAGULANT MARKERS DURING THROMBOLYTIC THERAPY IN PREDICTING CLINICAL OUTCOMES IN ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 78(5), 1996, pp. 503-510

Authors: LEVITAS A MCCANDLELESS G ELENWESKI E SOBEL B

Citation: A. Levitas et al., UNTITLED - COMMENTARY, MENTAL RETA, 32(5), 1994, pp. 366-366

Authors: MCGILL J SCHNEIDER D LUCORE C WEISS C NOCHOWIAK D SOBEL B

Citation: J. Mcgill et al., IMPAIRED FIBRINOLYSIS IN NIDDM AND OBESITY IS SECONDARY TO HYPERINSULINEMIA, Diabetes, 42, 1993, pp. 235-235

Authors: LOSCALZO J ABDENSCHEIN D EISENBERG P BECKER R GEORGE D MCCABE C SOBEL B BRAUNWALD E

Citation: J. Loscalzo et al., COMPARATIVE EFFECTS OF HEPARIN AND HIRUDIN ON FIBRINOLYTIC AND THROMBOTIC ACTIVITIES DURING TISSUE-TYPE PLASMINOGEN-ACTIVATOR THERAPY, Circulation, 88(4), 1993, pp. 200-200